Microbiology Diagnostic Devices And Equipment Market Size and Forecast 2024-2033|Danaher, Abbott Laboratories, Thermo Fisher Scientific, Becton Dickinson and Company, Biomerieux

The Microbiology Diagnostic Devices And Equipment by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Microbiology Diagnostic Devices And Equipment Market:

https://www.thebusinessresearchcompany.com/report/microbiology-diagnostic-devices-and-equipment-global-market-report

According to The Business Research Company’s Microbiology Diagnostic Devices And Equipment, The microbiology diagnostic devices and equipment market size has grown rapidly in recent years. It will grow from $4.49 billion in 2023 to $5.02 billion in 2024 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to increased healthcare expenditure, emerging markets growth, rapid technological advances, rapid growth in aging population and the emergence of novel pathogenic infestations

The microbiology diagnostic devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $7.74 billion in 2028 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to rise in funding, aging population, an increase in healthcare access and a rapid rise in various bacterial and viral epidemics. Major trends in the forecast period include growing adoption of predictive diagnostics, automation in the field of microbiology diagnostics, next generation microbial testing and increasing mergers and acquisitions.

Increasing funding of public and private investments in medical devices is driving the growth of the microbiology diagnostic devices market. Increasing Investments indicate the rising confidence of various private and public players on microbiology diagnostic devices, thereby indicating a progressive increase and stimulating growth. For instance, according to MedTech news, a publisher of new related to medical technology, private equity industry invested $111.8 B (c.$ 151 B) in healthTech industry. Furthermore, globally 96 deals valued at $40.8 billion were completed in medTech vertical. The increasing investments in digital health technologies, artificial intelligence and non-invasive monitoring capability, delivery of gene therapy and regenerative medicines technologies, and customized 3D printing of medical devices are expected to drive the microbiology diagnostic devices market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=3408&type=smp

The microbiology diagnostic devices and equipment market covered in this report is segmented –

1) By Type: Laboratory Instruments, Microbiology Analyzers, Reagents And Consumables

2) By Reagents: Pathogen-Specific Kits, General Reagents

3) By End-User: Diagnostic Laboratories, Hospitals, Other End-Users

Sub segments: Incubators, Gram Strainers, Bacterial Colony Counters, Petri Dish Fillers, Automated Culture Systems, Other Laboratory Instruments, Microscopes, Mass Spectrometers, Other Microbiology Analyzers, Oncology, Hormonal Disorder, Glaucoma, Other Therapeutic Applications

Next-Generation Sequencing (NGS) technologies are increasing their prevalence in the microbiology diagnostic devices market due to their cost effectiveness, sensitivity to detect low-frequency variants, and comprehensive genomic coverage. Next-Generation Sequencing (NGS) or high throughput sequencing or Massively Parallel Sequencing (MPS) is a method of sequencing genomes with the ability to sequence hundreds to thousands of genes or gene regions and the capability to detect novel resistance genes (ARG) in bacteria. BioMérieux partnered with Illumina to develop bioMérieux EpiSe, an NGS service that will facilitate epidemiological monitoring of bacterial infections and monitor outbreaks in hospitals. Some of the modern next-generation sequencing technologies that help to sequence DNA and RNA include Illumina (Solexa) sequencing, Roche 454 sequencing, Ion torrent Proton / PGM sequencing, and SOLiD sequencing.

The microbiology diagnostic devices and equipment market report table of contents includes:

1. Executive Summary

2. Microbiology Diagnostic Devices And Equipment Market Characteristics

3. Microbiology Diagnostic Devices And Equipment Market Trends And Strategies

4. Microbiology Diagnostic Devices And Equipment Market – Macro Economic Scenario

5. Global Microbiology Diagnostic Devices And Equipment Market Size and Growth

26. South America Microbiology Diagnostic Devices And Equipment Market

27. Brazil Microbiology Diagnostic Devices And Equipment Market

28. Middle East Microbiology Diagnostic Devices And Equipment Market

29. Africa Microbiology Diagnostic Devices And Equipment Market

30. Microbiology Diagnostic Devices And Equipment Market Competitive Landscape And Company Profiles

Top Major Players: